2 results
Approved WMOCompleted
This phase 3 trial will test the hypothesis that ponatinib is an effective treatment for newly diagnosed CP-CML patients when compared with standard imatinib
Approved WMOCompleted
To test the safety and feasibility of a closed loop controller of the FiO2 based on the measured SpO2 in a NICU setting.